21-10-2011

Researchers have identified a large number of areas in the human genetic code that are involved in regulating the way in which the liver functions, in a new study of over 61,000 people, published in Nature Genetics.The work is an international collaboration led by Imperial College London and ...

more

26-09-2011

NovImmune announced that a Proof-of–Concept (PoC) study with NI-0801, a fully human monoclonal antibody neutralizing the CXCL10/Interferon-gamma-inducible protein-10 (IP-10) chemokine, was initiated in patients with PBC. This is a chronic inflammatory, debilitating condition of the bile ducts ...

more

11-07-2011

Few treatments exist for patients with advanced primary liver cancer, but University of Florida researchers have found a new way to broaden the range of options and potentially improve health outcomes by combining two treatments.In the first study of its kind, the researchers combined ...

more

18-06-2010

The search for time and cost effective as well as sensitive methods for bioanalytical assays is currently of great interest. At the center of Biofunctional Nanomaterials in San Sebastian (Spain), Valery Pavlov and his co-workers are undertaking research in the area of the design and ...

more

26-03-2010

Humedics markets a method for instantaneous measurement of liver function at the patient’s bedside. Known as the LiMAx Test, which was developed at the Charité University Hospital in Berlin by Dr Martin Stockmann and refined into a measurement system together with Prof. Karsten Heyne of ...

more

Implications sought in human alcohol consumption, liver disease

26-10-2009

Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol. This metabolic switch also has implications for the deadly liver disease cirrhosis in humans. A counterpart human gene contributes ...

more

'FAIM' gene research conducted by Singapore scientists

06-07-2009

Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death. The scientists, Jianxin Huo, Ph.D., and Shengli Xu, ...

more

Pioneering technique uses microwaves

14-05-2009

Leicester consultant surgeon who has developed a pioneering technique using microwaves to destroy liver tumors has treated more than 100 patients in the UK and other patients are now being treated internationally. The incidence of primary liver cancer is gradually increasing in the Western ...

more

Raptor to Support Phase 2a Clinical Trial at UCSD

21-07-2008

Raptor Pharmaceuticals Corp. announced the execution of a collaboration agreement with the University of California, San Diego ("UCSD") to include a Phase 2a clinical trial to evaluate a delayed-release preparation of cysteamine bitartrate in adolescents diagnosed with Non-Alcoholic ...

more

07-07-2008

Movetis NV, a European specialist pharmaceutical company, announced that M0002 is progressing to phase IIb following positive results of a phase IIa multiple-dosing trial for the treatment of ascites, the accumulation of fluid in the abdomen in patients with liver cirrhosis resulting from ...

more